Lupus myocarditis is associated with lupus nephritis, positive anti-SSB antibodies, echocardiographic abnormalities, and higher mortality, with RTX emerging as a promising treatment.
What are the clinical features and associated factors of lupus myocarditis?
Lupus myocarditis is associated with lupus nephritis, anti-SSB antibodies, echocardiographic abnormalities, and higher mortality, with rituximab identified as a potential treatment.
Absolute Event Rate: 0% vs 0%
Patients with LM more frequently present with lupus nephritis and positive anti-SSB antibodies, are more likely to have echocardiographic abnormalities, and exhibit a higher mortality rate. In addition, RTX is a promising drug for LM treatment.
Yan et al. (Wed,) reported a other. Lupus myocarditis is associated with lupus nephritis, positive anti-SSB antibodies, echocardiographic abnormalities, and higher mortality, with RTX emerging as a promising treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: